IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1 +$23.4M
2 +$15.9M
3 +$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1 +$29.5M
2 +$19.7M
3 +$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
51
$4.32M 0.15%
+389,384
52
$4.28M 0.14%
+108,700
53
$4.12M 0.14%
111,500
-40,000
54
$4.1M 0.14%
775,294
-83,614
55
$4M 0.13%
+140,000
56
$4M 0.13%
+676,294
57
$3.97M 0.13%
31,353
+12,422
58
$3.83M 0.13%
23,016
-28,500
59
$3.8M 0.13%
415,000
60
$3.76M 0.13%
100,000
61
$3.73M 0.13%
153,941
-140,000
62
$3.64M 0.12%
936,615
63
$3.64M 0.12%
+31,700
64
$3.58M 0.12%
+187
65
$3.57M 0.12%
+70,160
66
$3.57M 0.12%
+1,714,366
67
$3.42M 0.12%
176,740
+145,021
68
$3.4M 0.11%
67,059
-50,000
69
$3.39M 0.11%
32,273
-3,560
70
$3.37M 0.11%
+341,500
71
$3.34M 0.11%
300,250
+150,738
72
$3.29M 0.11%
284,151
73
$3.23M 0.11%
304,739
+300,000
74
$3.2M 0.11%
1,160,450
-1,279,578
75
$3.16M 0.11%
49,925
-466,838